Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality.
The rapidly ageing population and the wide availability of wearable medical technology has resulted in ever-increasing number of patients diagnosed with atrial fibrillation.